Palvella Therapeutics, Inc. - Common Stock (NQ:PVLA)
100.84
-0.31
(-0.30%)
Streaming Delayed Price
Updated: 9:49 AM EST, Dec 30, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 6,162 |
| Open | 100.61 |
| Bid (Size) | 99.99 (100) |
| Ask (Size) | 101.70 (200) |
| Prev. Close | 101.15 |
| Today's Range | 100.61 - 101.89 |
| 52wk Range | 11.17 - 114.69 |
| Shares Outstanding | 98,935,025 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
Earnings Scheduled For November 11, 2025 ↗
November 11, 2025
Palvella Posts Cash Gain and Trial Wins ↗
August 14, 2025
Frequently Asked Questions
Is Palvella Therapeutics, Inc. - Common Stock publicly traded?
Yes, Palvella Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Palvella Therapeutics, Inc. - Common Stock trade on?
Palvella Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Palvella Therapeutics, Inc. - Common Stock?
The ticker symbol for Palvella Therapeutics, Inc. - Common Stock is PVLA on the Nasdaq Stock Market
What is the current price of Palvella Therapeutics, Inc. - Common Stock?
The current price of Palvella Therapeutics, Inc. - Common Stock is 100.84
When was Palvella Therapeutics, Inc. - Common Stock last traded?
The last trade of Palvella Therapeutics, Inc. - Common Stock was at 12/30/25 09:49 AM ET
What is the market capitalization of Palvella Therapeutics, Inc. - Common Stock?
The market capitalization of Palvella Therapeutics, Inc. - Common Stock is 9.98B
How many shares of Palvella Therapeutics, Inc. - Common Stock are outstanding?
Palvella Therapeutics, Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.